Goldman gave clients a list of stocks that may surge if a coronavirus vaccine is approved – CNBC

(This story is only for CNBC Pro subscribers)
With several Covid-19 vaccines in Phase 3 trials and preliminary data due as soon as later this month, Goldman Sachs is preparing its clients for a rebo…
Read More